Abeona Therapeutics Inc. ( ABEO) - Key Metrics
ABEO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.20 | -$0.35 | -$0.31 | -$0.32 |
| 2026Q1 | $0.15 | -$0.30 | -$0.35 | -$0.37 |
| 2025Q4 | $0.10 | -$0.39 | -$0.34 | -$0.36 |
| 2025Q3 | $0 | -$0.10 | -$0.39 | -$0.44 |
| 2025Q2 | $0.01 | $2.07 | -$0.36 | -$0.41 |
ABEO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.41 |
| 2026Q1 | 0% | -3.73 |
| 2025Q4 | 0% | -3.38 |
| 2025Q3 | 0% | -13.87 |
| 2025Q2 | 0% | 0.69 |
ABEO
Price: $4.96
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 254600
Ebitda: -5.2 millionMarket Capitalization: 293.5 million